Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits -- Ignore unavailable to you. Want to Upgrade?

To: MIKE DUBIS who wrote (208)	4/16/1998 7:15:00 PM
From: Colby	Read Replies (3) \| Respond to of 1016

My fellow VVUS investors (I happen to be long, but we're all playing the same company), First, I congratulate all of you who have shorted the stock. You all obviously made a better call than I did. Hows that sayin' "one person's loss is another person's gain." My question to all who care to answer, Are you still short VVUS? If so: How much of it is Short term Vs. long term? Technical Vs. Fundemental? What about the market PFE can't capture like moderate to severe ED patients? VVUS refill rate up slightly? (I know first time rx's are down, but who didn't know that was gonna happen?) Astra and Johansen have paid a lot of money to distribute this product. Does this lend any credibility to the product or the company? Are you worried about the short term impact of FDA approval (if they get it?) Unfortunately, it seems longs and shorts are not capable of communicating to one another, both pointing the finger at the other. In any event, I am long for what I think to be valid reasons, but I would like to hear the other side. At least in the old days when we used to fight, we used to do it on the same thread. I have to say, bookmarking two threads blows. Anyway, responses are appreciated, Colby